HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A prospective, randomized, blinded study of continuous ropivacaine infusion in the median sternotomy incision following cardiac surgery.

AbstractOBJECTIVE:
The aim of this prospective, randomized, double-blind, placebo controlled trial was to evaluate the safety and efficacy of continuous ropivacaine infusion of into the sternal wound.
METHODS:
We planned to enroll 200 patients scheduled for various cardiac surgical procedures into the study. Patients, in a double-blind randomized fashion, were given either normal saline or 0.3% ropivacaine through 2 subcutaneous multiport catheters placed on either side of the sternal split at an infusion rate of 4 mL/h for 64 hours. The efficacy outcomes measured were time to extubation of the trachea, intensive care unit and hospital stay duration, pain scores, and narcotic usage. The safety outcomes measured were systemic local anesthetic toxicity, major cardiac complications, and wound infection.
MEASUREMENTS AND MAIN RESULTS:
The data safety monitoring board stopped the study after enrolling 85 patients because of excessive sternal wound infections (9%, n = 44) in the ropivacaine group. This rate of infection was not statistically different from the control group (0%, n = 41, P = 0.12), but it was statistically different from our historical incidence of sternal wound infection (1.9%, no = 6381, P = 0.002). There was also a lack of evidence of efficacy for time to extubation of the trachea, narcotic usage, and pain control.
CONCLUSIONS:
The phase III trial did not show improvement in time to extubation of the trachea or pain control in the 0.3% ropivacaine group, but it was stopped early by the data safety monitoring board.
AuthorsShvetank Agarwal, Gregory A Nuttall, Michael E Johnson, Andrew C Hanson, William C Oliver Jr
JournalRegional anesthesia and pain medicine (Reg Anesth Pain Med) 2013 Mar-Apr Vol. 38 Issue 2 Pg. 145-50 ISSN: 1532-8651 [Electronic] England
PMID23386053 (Publication Type: Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Amides
  • Analgesics, Opioid
  • Anesthetics, Local
  • Ropivacaine
Topics
  • Aged
  • Airway Extubation
  • Amides (administration & dosage, adverse effects)
  • Analgesics, Opioid (therapeutic use)
  • Anesthetics, Local (administration & dosage, adverse effects)
  • Cardiac Surgical Procedures (adverse effects)
  • Double-Blind Method
  • Early Termination of Clinical Trials
  • Female
  • Humans
  • Infusions, Subcutaneous
  • Intensive Care Units
  • Length of Stay
  • Male
  • Middle Aged
  • Minnesota
  • Pain Measurement
  • Pain, Postoperative (diagnosis, etiology, prevention & control)
  • Prospective Studies
  • Ropivacaine
  • Sternotomy (adverse effects)
  • Surgical Wound Infection (etiology)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: